Financials

News Ideas Minds Technicals Forecast

CHRO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Chromocell Therapeutics Corporation

Total assets of CHRO for Q1 24 is 4.03 M USD, 4082.50% more than the previous Q4 23. And total liabilities decreased by 55.64% in Q1 24 to 2.9 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—